✦ LIBER ✦

Third-Line Sorafenib After Sequential Therapy With Sunitinib and mTOR Inhibitors in Metastatic Renal Cell Carcinoma

✍ Scribed by Giuseppe Di Lorenzo; Carlo Buonerba; Piera Federico; Pasquale Rescigno; Michele Milella; Cinzia Ortega; Michele Aieta; Carmine D’Aniello; Nicola Longo; Alessandra Felici; Enzo Maria Ruggeri; Giovannella Palmieri; Ciro Imbimbo; Massimo Aglietta; Sabino De Placido; Vincenzo Mirone

Book ID: 113612027
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 242 KB
Volume: 58
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2010.09.008

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sequential therapies with sorafenib and

Sequential therapies with sorafenib and sunitinib in advanced or metastatic renal cell carcinoma

✍ E. Herrmann; N. Marschner; M. O. Grimm; C. H. Ohlmann; U. Hutzschenreuter; F. Ov 📂 Article 📅 2011 🏛 Springer-Verlag 🌐 English ⚖ 347 KB

Sequential therapy with sorafenib and su

Sequential therapy with sorafenib and sunitinib in renal cell carcinoma

✍ Arkadiusz Z. Dudek; Jakub Zolnierek; Anu Dham; Bruce R. Lindgren; Cezary Szczyli 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 118 KB 👁 1 views

Sequential therapy with sunitinib and so

Sequential therapy with sunitinib and sorafenib in metastatic hepatocellular carcinoma

✍ Hee Kyung Ahn, Soohyeon Lee, Jong-Mu Sun, Jeeyun Lee, Se Hoon Park, Joon Oh Park 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 134 KB

Second-Line Treatment Outcomes After Fir

Second-Line Treatment Outcomes After First-Line Sunitinib Therapy in Metastatic Renal Cell Carcinoma

✍ Chi-Chang Chen; Gregory P. Hess; Zhimei Liu; Dean H. Gesme; Sanjiv S. Agarwala; 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 284 KB

Sequential Use of the Tyrosine Kinase In

Sequential Use of the Tyrosine Kinase Inhibitors Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma: A Retrospective Outcome Analysis

✍ Christian Eichelberg; Roman Heuer; Felix K. Chun; Kristin Hinrichs; Mario Zachar 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 326 KB

Objective response and time to progressi

Objective response and time to progression on sequential treatment with sunitinib and sorafenib in metastatic renal cell carcinoma

✍ Tomas Buchler, Tomas Pavlik, Zbynek Bortlicek, Alexandr Poprach, Rostislav Vyzul 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 176 KB